Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 1
2012 2
2013 4
2014 2
2015 3
2016 3
2017 4
2018 3
2019 7
2020 11
2021 16
2022 15
2023 12
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

74 results

Results by year

Filters applied: . Clear all
Page 1
A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia.
Cappellini MD, Viprakasit V, Taher AT, Georgiev P, Kuo KHM, Coates T, Voskaridou E, Liew HK, Pazgal-Kobrowski I, Forni GL, Perrotta S, Khelif A, Lal A, Kattamis A, Vlachaki E, Origa R, Aydinok Y, Bejaoui M, Ho PJ, Chew LP, Bee PC, Lim SM, Lu MY, Tantiworawit A, Ganeva P, Gercheva L, Shah F, Neufeld EJ, Thompson A, Laadem A, Shetty JK, Zou J, Zhang J, Miteva D, Zinger T, Linde PG, Sherman ML, Hermine O, Porter J, Piga A; BELIEVE Investigators. Cappellini MD, et al. N Engl J Med. 2020 Mar 26;382(13):1219-1231. doi: 10.1056/NEJMoa1910182. N Engl J Med. 2020. PMID: 32212518 Clinical Trial.
Luspatercept for the treatment of anaemia in non-transfusion-dependent β-thalassaemia (BEYOND): a phase 2, randomised, double-blind, multicentre, placebo-controlled trial.
Taher AT, Cappellini MD, Kattamis A, Voskaridou E, Perrotta S, Piga AG, Filosa A, Porter JB, Coates TD, Forni GL, Thompson AA, Tartaglione I, Musallam KM, Backstrom JT, Esposito O, Giuseppi AC, Kuo WL, Miteva D, Lord-Bessen J, Yucel A, Zinger T, Shetty JK, Viprakasit V; BEYOND Investigators. Taher AT, et al. Lancet Haematol. 2022 Oct;9(10):e733-e744. doi: 10.1016/S2352-3026(22)00208-3. Epub 2022 Aug 22. Lancet Haematol. 2022. PMID: 36007538 Clinical Trial.
Clinical Complications and Their Management.
Bou-Fakhredin R, Motta I, Cappellini MD, Taher AT. Bou-Fakhredin R, et al. Among authors: motta i. Hematol Oncol Clin North Am. 2023 Apr;37(2):365-378. doi: 10.1016/j.hoc.2022.12.007. Hematol Oncol Clin North Am. 2023. PMID: 36907609 Review.
Clinical Complications and Their Management.
Marcon A, Motta I, Taher AT, Cappellini MD. Marcon A, et al. Among authors: motta i. Hematol Oncol Clin North Am. 2018 Apr;32(2):223-236. doi: 10.1016/j.hoc.2017.11.005. Epub 2017 Dec 28. Hematol Oncol Clin North Am. 2018. PMID: 29458728 Review.
Innovative Treatments for Rare Anemias.
Cappellini MD, Marcon A, Fattizzo B, Motta I. Cappellini MD, et al. Among authors: motta i. Hemasphere. 2021 Jun 1;5(6):e576. doi: 10.1097/HS9.0000000000000576. eCollection 2021 Jun. Hemasphere. 2021. PMID: 34095760 Free PMC article. Review.
Acquired Refractory Iron Deficiency Anemia.
Migone De Amicis M, Rimondi A, Elli L, Motta I. Migone De Amicis M, et al. Among authors: motta i. Mediterr J Hematol Infect Dis. 2021 May 1;13(1):e2021028. doi: 10.4084/MJHID.2021.028. eCollection 2021. Mediterr J Hematol Infect Dis. 2021. PMID: 34007416 Free PMC article. Review.
74 results